Cong Fang

Title: Innovations of Cong Fang in Microfluidic Technology

Introduction

Cong Fang is an accomplished inventor based in Newbury Park, CA (US). He has made significant contributions to the field of microfluidics, particularly in the development of platforms for small sample analysis. His work focuses on integrating advanced technologies to enhance the capabilities of biochemical assays.

Latest Patents

Cong Fang holds a patent for an "Integrated microfluidic radioassay and imaging platform for small sample analysis." This innovative platform utilizes an immunocapture-based in vitro kinase assay on a polydimethylsiloxane (PDMS) microfluidics platform. It is capable of reproducibly measuring kinase activity from as few as 3,000 cells. The platform employs a standard radiometric P-ATP labeled phosphate transfer assay, which required the development of methods for repeated trapping and mixing of solid-phase affinity microbeads. A solid-state beta-particle camera embedded directly below the microfluidic device enables real-time quantitative detection of signals from this and other microfluidic radio bioassays. This integrated device can measure ABL protein kinase activity from BCR-ABL positive leukemia patient samples and assess small molecule phosphorylation, such as the phosphorylation of the deoxycytidine analog F-FAC by deoxycytidine kinase (dCK) isolated from cell lysates. Cong Fang has 1 patent to his name.

Career Highlights

Cong Fang's career is marked by his dedication to advancing microfluidic technologies. His innovative approaches have positioned him as a key figure in the field, particularly in applications related to cancer research and diagnostics. His work has the potential to significantly impact patient care by enabling more precise and efficient testing methods.

Collaborations

Cong Fang has collaborated with notable colleagues, including Thomas G Graeber and Hsian-Rong Tseng. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge technologies in the biomedical field.

Conclusion

Cong Fang's contributions to microfluidic technology exemplify the intersection of innovation and practical application in scientific research. His work continues to pave the way for advancements in small sample analysis and has the potential to improve diagnostic methods in healthcare.